SC 13D

Company

Protara Therapeutics, Inc.

Filed

November 3, 2014

Accession Number

0001104659-14-076010

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →